Heterogeneity of PNPT1 neuroimaging: mitochondriopathy, interferonopathy or both?

alkiviadis.1961 shared this article with you from Inoreader Heterogeneity of PNPT1 neuroimaging: mitochondriopathy, interferonopathy or both? Via JMG Online First Background Biallelic variants in PNPT1 cause a mitochondrial disease of variable severity. PNPT1 (polynucleotide phosphorylase) is a mitochondrial protein involved in RNA processing where it has a dual role in the import of small RNAs into mitochondria and in preventing the formation and release of mitochondrial double-stranded RNA into the cytoplasm. This, in turn, prevents the activation of type I interferon response. Detailed neuroimaging findings in PNPT1-related disease are lacking with only a few patient s reported with basal ganglia lesions (Leigh syndrome) or non-specific signs. Objective and methods To document neuroimaging data in six patients with PNPT1 highlighting novel findings. Results Two patients exhibited striatal lesions compatible with Leigh syndrome; one patient exhibited leukoencephalopathy and one patient had a normal brain MRI. Interestingly, two unrelated patients exhibited cystic leukoencephalopathy resembling RNASET2-deficient patients, patients with Aicardi-Goutières syndrome (AGS) or congenital CMV infection. Conclusion We suggest that similar to RNASET2, PNPT1 be searched for in the setting of cystic leukoencephalopathy. These findings are in line with activation of type I interferon response observed in AGS, PNPT1 and RNASET2 deficiencies, suggesting a common pathophysiological pathway and linking mitochondrial diseases, interferonopathies and immune dysregulations. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.